Novel Glucose-Lowering Medications and Impact on Diabetic Retinopathy
Join Drs. Singh and Barkmeier as they discuss they review findings on the impact of GLP-1 receptor agonists and SGLT2 inhibitors on diabetic retinopathy risk.
New Content
Clinical Studies & Trials
The Link Between Ellipsoid Zone Integrity and Functional Vision Loss in Geographic Atrophy
August 7, 2026
Practice Management
Going Solo in Retina: A Practical Guide to Launching an Independent Practice
July 31, 2026
Clinical Studies & Trials
ERLYDEX Study Results of Dexamethasone Implantation in Clinical Practice
July 21, 2026
Evidence Based Retina
Recently Published
CLINICAL STUDIES & TRIALS
A Closer Look at Qlosi and the Bascom Pupil Selectivity Analysis
Join Drs. Rishi Singh, Nicole Fram, and Mary Beth Yackey as they delve into the Bascom pupil selectivity analysis of new generation presbyopia-correcting drops.
FELLOWSHIP
Inside Mass Eye and Ear's Vitrectomy Course: A 16-Year Model for First-Year Fellow Training
Join Drs. Singh and Miller as they discuss the 16th annual Vitrectomy Course for first-year fellows and the model behind the program.
Rishi P. Singh, MD, FASRS, John Miller, MDJuly 7, 2026
CLINICAL STUDIES & TRIALS
How the New 5-Year SYFOVRE Data May Impact GA Treatment
Sit down with Drs. Singh and Dhoot as they review 5-year GALE trial data on SYFOVRE (pegcetacoplan) for the treatment of geographic atrophy (GA).
Rishi P. Singh, MD, FASRS, Dilsher Dhoot, MDJune 30, 2026
OPHTHALMOLOGY INDUSTRY INFO
Increasing Access to Anti-VEGF Therapies for Retina Clinics
Rishi P. Singh, MD, FASRS, Thomas W. Stone, MDJune 18, 2026
PHARMACEUTICALS
Revolutionizing Retina Treatments to Preserve Sight
Rishi P. Singh, MD, FASRS, Carlos Quezada-Ruiz, MD, FASRSJune 11, 2026